摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-pentenyl)glycine methyl ester | 151239-71-3

中文名称
——
中文别名
——
英文名称
N-(4-pentenyl)glycine methyl ester
英文别名
methyl N-pent-4-en-1-ylglycinate;methyl N-(pent-4-enyl)glycinate;Methyl 2-(pent-4-enylamino)acetate
N-(4-pentenyl)glycine methyl ester化学式
CAS
151239-71-3
化学式
C8H15NO2
mdl
——
分子量
157.213
InChiKey
UXXKHFMQOCNOMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    204.8±23.0 °C(Predicted)
  • 密度:
    0.935±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N-(4-pentenyl)glycine methyl esterRuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 作用下, 以 甲醇甲苯 为溶剂, 反应 59.0h, 生成
    参考文献:
    名称:
    烯丙基羟基膦酸酯:多功能手性构件
    摘要:
    使用一系列钯催化的反应,将烯丙基羟基膦酸酯转化为β和γ取代的氨基膦酸酯。氮亲核试剂和钯催化剂的明智选择可以实现出色的区域和立体化学控制。钯(0)催化的胺加成或甲苯磺酸氨基甲酸酯重排产生γ-取代的膦酸酯,而甲苯磺酸氨基甲酸酯与钯(II)和碱的反应产生恶唑烷酮(β-取代)。
    DOI:
    10.1016/j.jorganchem.2004.11.019
  • 作为产物:
    描述:
    甘氨酸甲酯盐酸盐5-溴-1-戊烯potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 49.0h, 以68.1%的产率得到N-(4-pentenyl)glycine methyl ester
    参考文献:
    名称:
    分子内亲核试剂催化的醛醇内酯化(NCAL)的Aza变体:(3 S,4 R)和(3 R,4 S)4-(羟甲基)吡咯烷丁-3-醇的正式合成
    摘要:
    已经探索了分子内催化,不对称亲核催化剂催化的醛醇内酯化(NCAL)反应的氮杂变体,以通过使用非手性氨基酸来合成β-内酯稠合的氮杂环作为氮杂糖的前体。这些双环β-内酯的用途通过氮杂糖,(3 S,4 R)和(3 R,4 S)4-(羟甲基)吡咯烷丁-3-醇的形式合成来表示。
    DOI:
    10.1016/j.tet.2010.10.085
点击查看最新优质反应信息

文献信息

  • A Highly Practical RCM Approach towards a Molecular Building Kit of Spirocyclic Reverse Turn Mimics
    作者:Holger Bittermann、Frank Böckler、Jürgen Einsiedel、Peter Gmeiner
    DOI:10.1002/chem.200600432
    日期:2006.8.16
    privileged molecular scaffolds efficiently mimicking reverse turn motifs and thus increasing both binding and selectivity and enabling the elucidation of the bioactive conformation of a natural peptide has attracted remarkable interest. The frequent occurrence of proline in various turn patterns initiated the design of proline-based reverse turn mimetics. As a structural hybridization of a highly potent
    特权分子支架的开发有效地模仿了反向转位基序,从而增加了结合和选择性,并使得能够阐明天然肽的生物活性构象引起了人们的极大兴趣。脯氨酸在各种转弯模式中的频繁出现启动了基于脯氨酸的反向转弯模拟物的设计。作为高效模拟VI型IIβ转角的高效VI型β转角诱导物1与饱和螺环内酰胺3的结构杂交,当Seebach的手性方法的自我复制获得成功时,我们开发了一条通向2型不饱和螺环内酰胺的通用合成路线。与肽偶联反应和Grubbs的闭环复分解反应相结合。通过这种方式,遵循统一的途径,可以获得具有六至九元内酰胺环的各种模型肽。将适当保护的模板引入固相肽合成中会产生天然存在的神经肽神经降压素的不饱和螺环类似物。在高水平的理论上进行的光谱研究和DFT计算表明,反向旋转诱导能力对环尺寸的显着依赖性。尽管不饱和螺环ε-内酰胺12的二级结构与参考γ-内酰胺3a非常吻合,但不饱和δ-内酰胺11却具有超强的β-转角诱导作用,甚至优于3b型β-内酰胺。
  • Molecular Building Kit of Fused-Proline-Derived Peptide Mimetics Allowing Specific Adjustment of the Dihedral Ψ Angle
    作者:Juergen Einsiedel、Harald Lanig、Reiner Waibel、Peter Gmeiner
    DOI:10.1021/jo701703e
    日期:2007.11.1
    [Graphics]Proline-derived peptide mimetics have become an area of paramount importance in peptide and protein chemistry. Since protein crystal structures frequently display W angles of 140-170 degrees for prolyl moieties, our intention was to design a completely novel series of 2,3-fused-proline-derived lactams covering this particular conformational space. Extending our recently described toolset of spirocyclic reverse-turn mimetics, we synthesized pyrrolidinyl-fused seven-, eight-, and nine-membered unsaturated lactam model peptides taking advantage of Grubbs' ring-closing metathesis. Investigating the seven-membered lactam 3a by means of IR and NMR spectroscopy and semiempirical molecular dynamics simulations, we could not observe a U-turn conformation; however, increasing the ring size to give eight- and nine-membered congeners revealed moderate and high type II P-turn inducing properties. Interestingly, the conformational properties of our model systems depend on both the ring size of the fused dehydro-Freidinger lactam and the position of the endocyclic double bond. Superior reverse-turn inducing properties could be observed for the fused azacyclononenone 3e. According to diagnostic transanular NOEs, a discrete folding principle of the lactam ring strongly deviating from the regioisomeric lactams 3c,f explains the conformational behavior. Hence, we were able to establish a molecular building kit that allows adjustments of a wide range of naturally occurring proline W angles and thus can be exploited to probe molecular recognition and functional properties of biological systems.
  • Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists
    作者:Fa Liu、Andrew G. Stephen、Abdul A. Waheed、Eric O. Freed、Robert J. Fisher、Terrence R. Burke
    DOI:10.1016/j.bmcl.2009.10.105
    日期:2010.1
    HIV-1 viral budding involves binding of the viral Gag(p6) protein to the ubiquitin E2 variant domain of the human tumor susceptibility gene 101 protein (Tsg101). Recognition of p6 by Tsg101 is mediated in part by a proline-rich motif that contains the sequence 'Pro-Thr-Ala-Pro' ('PTAP'). Using the p6-derived 9-mer sequence 'PEPTAPPEE', we had previously improved peptide binding affinity by employing N-alkylglycine ('peptoid') residues. The current study applies ring-closing metathesis macrocyclization strategies to Tsg101-binding peptide-peptoid hybrids as an approach to stabilize binding conformations and to observe the effects of such macrocyclization on Tsg101-binding affinity and bioavailability. Published by Elsevier Ltd.
  • Cross-metathesis of N-alkenyl peptoids with O- or C-allyl glycosides
    作者:Yun-Jin Hu、Rene´ Roy
    DOI:10.1016/s0040-4039(99)00481-5
    日期:1999.4
    Cross-metathesis of several N-alkenyl-containing oligoglycines derivatives (peptoids) with protected O-or C-allyl glycosides of N-acetylglucosamine, galactose, and mannose using Grubbs' ruthenium benzylidene catalyst (Cy3P)(2)Cl2Ru=CHPh (1) has been achieved in 40 to 52% yields. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • C8-CYCLIC PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP0610432A1
    公开(公告)日:1994-08-17
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物